INOVIO PHARMACEUTICALS, INC. 4
4 · INOVIO PHARMACEUTICALS, INC. · Filed Mar 13, 2017
Insider Transaction Report
Form 4
Bagarazzi Mark
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2017-03-09+25,000→ 50,758 total - Tax Payment
Common Stock
2017-03-09$6.61/sh−7,648$50,553→ 43,110 total - Exercise/Conversion
Restricted Stock Unit
2017-03-09−25,000→ 50,000 total→ Common Stock (25,000 underlying) - Award
Restricted Stock Unit
2017-03-10+61,300→ 61,300 total→ Common Stock (61,300 underlying) - Award
Common Stock Options
2017-03-10$6.68/sh+100,000$668,000→ 100,000 totalExercise: $6.68From: 2017-03-10Exp: 2027-03-10→ Common Stock (100,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 75,000 restricted stock units is as follows: 25,000 shares vested on March 9, 2017; 25,000 shares will vest on March 9, 2018; 25,000 shares will vest on March 9, 2019. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.
- [F2]The vesting schedule for the 100,000 options is as follows: 25,000 shares vested on March 10, 2017; 25,000 shares will vest on March 10, 2018; 25,000 shares will vest on March 10, 2019; 25,000 shares will vest on March 10, 2020.
- [F3]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 61,300 restricted stock units is as follows: 20,433 shares will vest on March 10, 2018; 20,434 shares will vest on March 10, 2019; 20,433 shares will vest on March 10, 2020. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.